Prime Capital Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,942
Closed -$219K 1100
2025
Q1
$219K Buy
+3,942
New +$213K ﹤0.01% 944
2024
Q1
Sell
-4,040
Closed -$201K 1041
2023
Q4
$201K Buy
+4,040
New +$198K ﹤0.01% 882
2019
Q1
Sell
-279
Closed -$12K 440
2018
Q4
$12K Buy
+279
New +$12.3K ﹤0.01% 259

Other funds holding SNY

Prime Capital Investment Advisors's SNY Position: Q2 2025 in Review

Prime Capital Investment Advisors sold out of Sanofi (SNY) in Q2 2025, closing a stake of 3,942 shares — an estimated $219K sold.

Prime Capital Investment Advisors first reported a position in SNY in Q4 2018 and held it in 3 quarters. The position peaked at $219K in Q1 2025. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Prime Capital Investment Advisors reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 3,942 Sanofi shares in Q2 2025, an estimated $219K.
  • Prime Capital Investment Advisors first reported a position in Sanofi in Q4 2018 and held it in 3 quarters.
  • Prime Capital Investment Advisors's Sanofi position peaked at $219K in Q1 2025.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.